Professor of Medicine
Johns Hopkins University School of Medicine
Disclosure(s): AbbVie: Advisor/Consultant; Aligos: Advisor/Consultant, Grant/Research Support; Gilead: Advisor/Consultant; Grifols: Grant/Research Support; GSK: Advisor/Consultant, Grant/Research Support; Pfizer: Advisor/Consultant; Precision Biosciences: Advisor/Consultant; Vir: Advisor/Consultant, Grant/Research Support; Virion: Advisor/Consultant
Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at the Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center and is the Senior Associate Dean for Research for Clinical Trials. He received his MD from Temple University School of Medicine, pursued training in Internal Medicine at Duke and completed his Fellowship in Infectious Diseases at Johns Hopkins.
Prof. Sulkowski has been the principal investigator for more than 200 clinical trials related to viral hepatitis B and C in persons with and without HIV coinfection. He was the global principal investigator for more than a dozen trials, including the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the ACTG where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation and the American Association of Physicians.
Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries.